NB
Neena Bitritto-Garg Deutsche Bank Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Acadia Pharmaceuticals
ACAD
$4.28B
| $24.84 | $22 |
11%
downside
| Hold |
11 Feb ‘25
7 months ago |
|
2
Roivant Sciences
ROIV
$9.21B
| $13.48 | $15 |
11%
upside
| Buy |
3 Apr ‘24
1 year ago |
|
3
Amylyx Pharmaceuticals
AMLX
$937M
| $10.51 | $8 |
24%
downside
| Buy |
11 Mar ‘24
1 year ago |
|
4
Immunovant
IMVT
$2.86B
| $16.40 | $50 |
205%
upside
| Buy |
12 Dec ‘23
1 year ago |
|
5
Neurocrine Biosciences
NBIX
$14.3B
| $144.17 | $136 |
6%
downside
| Buy |
12 Dec ‘23
1 year ago |
|
|
CMPS
6
Compass Pathways
CMPS
$496M
| $5.17 | $16 |
209%
upside
| Buy |
12 Dec ‘23
1 year ago |
|
7
Prothena Corp
PRTA
$449M
| $8.34 | $62 |
643%
upside
| Buy |
12 Dec ‘23
1 year ago |
|
8
Alector
ALEC
$283M
| $2.80 | $12 |
329%
upside
| Buy |
12 Dec ‘23
1 year ago |
|
9
Sarepta Therapeutics
SRPT
$1.85B
| $17.64 | $109 |
518%
upside
| Buy |
12 Dec ‘23
1 year ago |
|
10
Acumen Pharmaceuticals
ABOS
$87.2M
| $1.44 | $8 |
456%
upside
| Buy |
12 Dec ‘23
1 year ago |
|
|
11
Acadia Pharmaceuticals
ACAD
$4.28B
| $24.84 | $27 |
9%
upside
| Neutral |
14 Jul ‘23
2 years ago |
|
|
12
Sarepta Therapeutics
SRPT
$1.85B
| $17.64 | $204 |
1,056%
upside
| Buy |
23 Jun ‘23
2 years ago |
|
|
13
Neurocrine Biosciences
NBIX
$14.3B
| $144.17 | $122 |
15%
downside
| Buy |
4 May ‘23
2 years ago |
|
|
CMPS
14
Compass Pathways
CMPS
$496M
| $5.17 | $19 |
268%
upside
| Buy |
1 Mar ‘23
2 years ago |
|
|
15
Alector
ALEC
$283M
| $2.80 | $12 |
329%
upside
| Buy |
1 Mar ‘23
2 years ago |
|
|
16
Prothena Corp
PRTA
$449M
| $8.34 | $72 |
763%
upside
| Buy |
27 Feb ‘23
2 years ago |
|
17
ATAI Life Sciences
ATAI
$1.05B
| $4.89 | $10 |
105%
upside
| Buy |
9 Jan ‘23
2 years ago |
|
|
18
Roivant Sciences
ROIV
$9.21B
| $13.48 | $14 |
4%
upside
| Buy |
5 Jan ‘23
2 years ago |
|
19
Passage Bio
PASG
$22.3M
| $7 | $100 |
1,329%
upside
| Buy |
11 Nov ‘22
2 years ago |
|
|
20
Amylyx Pharmaceuticals
AMLX
$937M
| $10.51 | $50 |
376%
upside
| Buy |
3 Oct ‘22
2 years ago |
|
21
Kodiak Sciences
KOD
$517M
| $10.06 | $6 |
40%
downside
| Sell |
2 Aug ‘22
3 years ago |
|
22
Alpha Tau Medical
DRTS
$314M
| $3.90 | $21 |
438%
upside
| Buy |
4 Apr ‘22
3 years ago |
|